What is Chemours Company Annual Revenue?

Chemours Company Annual Revenue fell 4.87%, in the last year to $5,782 M. Its sector's average revenue growth for the last fiscal year was -3.94%.

What is Chemours Company Annual Net Profit?

Chemours Company Annual Net Profit rose 136.13% in the last year to $86 M. Its sector's average net profit growth for the last fiscal year was -215.51%.

What is Chemours Company Price to Earning Ratio?

Chemours Company Price to Earning Ratio is 18.93, lower than its sector PE ratio of 26.56.

What is Chemours Company Stock Price?

Chemours Company Stock Price fell 57.47% and underperformed its sector by 50.48% in the past year.

What is Chemours Company Quarterly Revenue?

Chemours Company Quarterly Revenue fell 1.27% YoY to $1,394 M. Its sector's average revenue growth YoY for the quarter was -0.94%.

What is Chemours Company Quarterly Net profit?

Chemours Company Quarterly Net profit rose 55.56% YoY to $8 M. Its sector's average net profit growth YoY for the quarter was -241.61%.

What is Chemours Company Debt to Equity Ratio?

Chemours Company Debt to Equity Ratio of 7.21 is higher than 1. This implies that company assets are financed through debt.

What is Chemours Company Return on Equity(ROE)?

Chemours Company Return on Equity(ROE) for the last financial year was 12.83%, in the normal range of 10% to 20%.

What is Chemours Company Mutual Fund Holding?

Chemours Company Mutual Fund Holding increased by 10.41% in the last quarter to 71.73.

What is Chemours Company Promoter Share Holding?

Chemours Company Promoter Share Holding increased by 0.18% in the most recent quarter to 0.57%.

What is Chemours Company Interest Coverage Ratio?

Chemours Company Interest Coverage Ratio is 1.48, in the normal range of 1 to 1.5.

What is Chemours Company Institutional Holding?

Chemours Company Institutional Holding increased by 0.01% in the last quarter to 85.14.

How is the Chemours Company today?

The Chemours Company today is trading in the down by -2.99% at 11.02.

How has Chemours Company performed historically?

The Chemours Company is currently trading down -2.99% on an intraday basis in the past week the index fell -2.30%. The index has been down -43.20% in the past quarter and fell -57.47% in the past year. You can view this in the overview section.

Chemours Company XNYS: CC

Chemours Company Live Share Price Today, Share Analysis and Chart

Name: Chemours Company: Is Infosys Ltd. worth buying?
Item: Chemours Company
Rating: 2.201514
Author: Trendlyne DVM scores

Falling Comet

Download real time

11.02 -0.34 (-2.99%)

62.27% Fall from 52W High

268.8K XNYS Volume

XNYS 21 Apr, 2025 11:39 AM (EDT)

Board Meeting

The next board meeting for Chemours Company is on 01 May 2025 for the purpose of The Chemours Co First Quarter Earnings Conference Call for 2025 See details

Chemours Company Key Metrics

My Metrics

Default

Market Capitalization Below industry Median Unavailable in chosen country	1,646.8
PE TTM High in industry Unavailable in chosen country	18.9
PEG TTM Below industry Median Unavailable in chosen country	0.1
Price to Book Below industry Median Unavailable in chosen country	2.7
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	85.1
Revenue Growth Qtr YoY % Negative Revenue Growth Qtr YoY % Unavailable in chosen country	-1.3
Operating Revenue growth TTM % Negative Operating Revenue growth TTM % Unavailable in chosen country	-4.9
Net Profit Qtr Growth YoY % Below industry Median Unavailable in chosen country	55.6
Net Profit TTM Growth % High in industry Unavailable in chosen country	136.7
Operating Profit Margin Qtr % Below industry Median Unavailable in chosen country	5.4
Operating Profit Margin TTM % Below industry Median Unavailable in chosen country	7.7
Piotroski Score High in industry Unavailable in chosen country	6
Rel Perf vs Sector quarter% Unavailable in chosen country	-34.1
ROE Annual % Below industry Median Unavailable in chosen country	12.8
RoA Annual % Below industry Median Unavailable in chosen country	1.1

All financials are in USD Million and price data in USD

High Financial Strength

55.6 / 100

Mid Valuation

33.5 / 100

Technically Bearish

31.5 / 100

Falling Comet These stocks are the ones with good quality and mid-range financial aspects. However, their weak technical aspect reduces the investor's interest. View Similar Embed DVM

1Yr Price target upside is 77%

10 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Sell Zone

68.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Chemours Company Stock Price Analysis

Day Price Range -3.0% 1 Day return Unavailable in chosen country	11 (LTP) 1111.2 LowHigh
Week Price Range -2.3% 1 Week return Unavailable in chosen country	11 (LTP) 10.711.7 LowHigh
Month Price Range -24.9% 1 Month return Unavailable in chosen country	11 (LTP) 9.314.7 LowHigh
52 Week Price Range -57.5% 1 Year return Unavailable in chosen country	11 (LTP) 9.329.2 LowHigh

View full Share Price History

Chemours Company Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Chemours Company's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

0.6

Avg. Estimate

1.8

Low Estimate

1.8

High Estimate

1.8

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 215.8% in FY25

Consensus Recommendation

10 ANALYST Recommendations

BUY

The consensus recommendation from 10 analysts for Chemours Company is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Chemours Company Stock Analysis

Chemours Company stock analysis with key metrics, changes, and trends.

Chemours Company Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$5,782 M	4.87%	negative	Annual Revenue fell 4.87%, in the last year to $5,782 M. Its sector's average revenue growth for the last fiscal year was -3.94%.
Annual Net Profit	$86 M	136.13%	positive	Annual Net Profit rose 136.13% in the last year to $86 M. Its sector's average net profit growth for the last fiscal year was -215.51%.
Price to Earning Ratio	18.93	-	positive	Price to Earning Ratio is 18.93, lower than its sector PE ratio of 26.56.
Stock Price	$11.02	-57.47%	negative	Stock Price fell 57.47% and underperformed its sector by 50.48% in the past year.
Quarterly Revenue	$1,394 M	1.27%	negative	Quarterly Revenue fell 1.27% YoY to $1,394 M. Its sector's average revenue growth YoY for the quarter was -0.94%.
Quarterly Net profit	$8 M	55.56%	positive	Quarterly Net profit rose 55.56% YoY to $8 M. Its sector's average net profit growth YoY for the quarter was -241.61%.
Debt to Equity Ratio	7.21	-	negative	Debt to Equity Ratio of 7.21 is higher than 1. This implies that company assets are financed through debt.
Return on Equity(ROE)	12.83 %	12.83%	neutral	Return on Equity(ROE) for the last financial year was 12.83%, in the normal range of 10% to 20%.
Mutual Fund Holding	71.73 %	10.41%	positive	Mutual Fund Holding increased by 10.41% in the last quarter to 71.73.
Promoter Share Holding	0.57 %	0.18%	positive	Promoter Share Holding increased by 0.18% in the most recent quarter to 0.57%.
Interest Coverage Ratio	1.48	-	neutral	Interest Coverage Ratio is 1.48, in the normal range of 1 to 1.5.
Institutional Holding	85.14 %	0.01%	positive	Institutional Holding increased by 0.01% in the last quarter to 85.14.

VIEW LESS

Loading data..

Chemours Company - Company Profile

What does Chemours Company do?

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Gross Remuneration

2025

Gross Remuneration

Year

Chemours Company Live Share Price Today, Share Analysis and Chart

62.27% Fall from 52W High

Chemours Company Key Metrics

Market Capitalization

PE TTM

PEG TTM

Rel Perf vs Sector quarter%

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

ROE Annual %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

RoA Annual %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Operating Profit Margin Qtr %

Operating Profit Margin TTM %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Chemours Company Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Chemours Company Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Chemours Company's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

EPS is expected to grow by 215.8% in FY25

Consensus Recommendation

The consensus recommendation from 10 analysts for Chemours Company is BUY

Chemours Company Stock Analysis

Chemours Company stock analysis with key metrics, changes, and trends.

Annual Revenue fell 4.87%, in the last year to $5,782 M. Its sector's average revenue growth for the last fiscal year was -3.94%.

Annual Net Profit rose 136.13% in the last year to $86 M. Its sector's average net profit growth for the last fiscal year was -215.51%.

Price to Earning Ratio is 18.93, lower than its sector PE ratio of 26.56.

Stock Price fell 57.47% and underperformed its sector by 50.48% in the past year.

Quarterly Revenue fell 1.27% YoY to $1,394 M. Its sector's average revenue growth YoY for the quarter was -0.94%.

Quarterly Net profit rose 55.56% YoY to $8 M. Its sector's average net profit growth YoY for the quarter was -241.61%.

Debt to Equity Ratio of 7.21 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE) for the last financial year was 12.83%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 10.41% in the last quarter to 71.73.

Promoter Share Holding increased by 0.18% in the most recent quarter to 0.57%.

Interest Coverage Ratio is 1.48, in the normal range of 1 to 1.5.

Institutional Holding increased by 0.01% in the last quarter to 85.14.

Chemours Company - Company Profile

What does Chemours Company do?

Chemours Company Management structure

Ms. Denise M. Dignam

Director, President and Chief Executive Officer

Mr. Matthew S. Abbott

Senior Vice President and Chief Enterprise Transformation Officer

Ms. Kristine Wellman

Senior Vice President, General Counsel and Corporate Secretary

Mr. Joseph T. Martinko

President, Thermal and Specialized Solutions

Mr. Gerardo Familiar Calderon

President, Advanced Performance Materials

Mr. Shane W. Hostetter

Chief Financial Officer and Senior Vice President

Chemours Company Board of directors

Mr. Joseph D. Kava